Back to Search Start Over

Serum IL-5, POSTN and IL-33 levels in chronic rhinosinusitis with nasal polyposis correlate with clinical severity.

Authors :
Zielińska-Bliźniewska, Hanna
Paprocka-Zjawiona, Milena
Merecz-Sadowska, Anna
Zajdel, Radosław
Bliźniewska-Kowalska, Katarzyna
Malinowska, Katarzyna
Source :
BMC Immunology; 6/25/2022, Vol. 23 Issue 1, p1-12, 12p
Publication Year :
2022

Abstract

Background: Chronic rhinosinusitis (CRS) is a group of heterogeneous diseases characterized by epithelial inflammation and tissue eosinophilic infiltration. IL-5, POSTN, and IL-33 are important factors that act as chemoattractants for eosinophils, and a tissue-remodeling protein positively correlated with eosinophils in blood and mediators of eosinophilic infiltration. The aim of the study was to determine the expression of IL-5, POSTN and IL-33, at the gene and protein levels, in eosinophilic CRS with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP), and to correlate this expression with clinical severity. Materials and methods: The study included 40 CRSwNP patients and 53 CRSsNP patients and 40 control subjects. The expression of IL-5, POSTN and IL-33 mRNA was determined in sinonasal mucosal samples and in nasal polyp tissue by real-time PCR. Protein levels in the serum of CRSwNP patients were measured by ELISA. Computed tomography was evaluated according to Lund–Mackay scores, and visual analog scale scores were assessed. Results: NP tissue demonstrated significantly higher IL-5 and POSTN mRNA expression than the sinonasal tissue in the CRSsNP and CRSwNP groups. CRS groups demonstrated elevated IL-33 mRNA expression in comparison to controls irrespective of the presence of NP. No correlation was found between IL-5, POSTN and IL-33 mRNA expression and disease severity. CRSwNP group demonstrated significantly higher serum IL-5, POSTN and IL-33 protein levels than controls, and this corresponds to disease severity. Conclusion: Serum IL-5, POSTN and IL-33 levels may be important markers for classification of eosinophilic CRSwNP patients, along with disease severity. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14712172
Volume :
23
Issue :
1
Database :
Complementary Index
Journal :
BMC Immunology
Publication Type :
Academic Journal
Accession number :
157630750
Full Text :
https://doi.org/10.1186/s12865-022-00507-2